AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Moderna, Inc. Director's Dealing 2020

Jun 9, 2020

30610_dirs_2020-06-09_aace9897-532f-40a9-bb18-df4808a0d4b3.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Moderna, Inc. (MRNA)
CIK: 0001682852
Period of Report: 2020-06-08

Reporting Person: Meline David W (Chief Financial Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1500	Direct